Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  solid tumor
Stage/Subtype:  solid tumor
Trial Type:  Prevention
Treatment/Intervention:  vaccine therapy
Results 1-7 of 7 for your search:
Start Over
Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: 116428, NCI-2014-01414, 2012-003438-18, NCT01767467
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 13 to 26
Trial IDs: AMC-072, NCI-2011-02510, CDR0000685816, NCT01209325
Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
Phase: Phase II
Type: Prevention
Age: 18 and over
Trial IDs: 368255, NCI-2015-00026, 1137008 / 20130058, NCT01570036
Vaccine Therapy in Treating Patients with Newly Diagnosed Advanced Colon Polyps
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 40 to 70
Trial IDs: MAY2013-01-01, NCI-2014-01080, HHSN261201200042I, N01-CN-2012-00042, NCT02134925
Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients
Phase: Phase II
Type: Prevention
Age: 18 and over
Trial IDs: 2014-0443, NCI-2015-00033, NCT02297698
Prostvac (PSA-TRICOM) in Preventing Disease Progression in Patients with Localized Prostate Cancer Undergoing Active Surveillance
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: Not specified
Trial IDs: 1410547210, NCI-2014-02556, AZ027, HHSN2612012000311, N01-CN-2012-00031, UAZ2014-03-01, NCT02326805
Vaccine Therapy with or without Imiquimod in Treating Patients with High-Grade Cervical Intraepithelial Neoplasia
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Prevention
Age: 18 and over
Trial IDs: J0656, NCI-2011-00532, CDR0000617261, CIR00001225, JHOC-J0656, NA_00002176, NCT00788164
Start Over